Comparison of Nocturnal Cough Analysis in Healthy Subjects and in Patients with Cystic Fibrosis and Primary Ciliary Dyskinesia: A Prospective Observational Study
Background: Cough is a key symptom in patients with cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). Objective: The study objectives were to test whether cough is related to parameters reflecting their disease severity and whether CF and PCD differ in cough frequency. Methods: In this pros...
Saved in:
Published in | Respiration Vol. 97; no. 1; pp. 60 - 69 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Basel, Switzerland
01.01.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background: Cough is a key symptom in patients with cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). Objective: The study objectives were to test whether cough is related to parameters reflecting their disease severity and whether CF and PCD differ in cough frequency. Methods: In this prospective observational study, we used a microphone-based monitoring system (LEOSound® Monitor) to count the coughs in healthy subjects (HS) and in stable patients with CF and PCD (25 subjects per group) on 2 consecutive nights. Results: The median number of coughs/h in the HS, CF, and PCD groups was 0.0, 1.3, and 0.5 on the first night and 0.0, 2.3, and 0.2 on the second night, respectively. Patients with CF and PCD coughed more than HS (p < 0.001 and p = 0.009, respectively) and CF patients coughed more than PCD patients (p = 0.023). A multivariable mixed model analysis revealed forced expiratory volume in 1 s as an independent risk factor for increased cough frequency in patients. The reliability for repeated measurements was higher for cough epochs/h than for coughs/h (intraclass correlation coefficient: 0.75 and 0.49, respectively). Conclusions: Patients with CF cough more than patients with PCD. The cough frequency in CF and PCD is associated with parameters reflecting disease severity. Cough frequency is a possible endpoint in clinical trials and cough epochs/h may be more useful than coughs/h. |
---|---|
AbstractList | Background: Cough is a key symptom in patients with cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). Objective: The study objectives were to test whether cough is related to parameters reflecting their disease severity and whether CF and PCD differ in cough frequency. Methods: In this prospective observational study, we used a microphone-based monitoring system (LEOSound® Monitor) to count the coughs in healthy subjects (HS) and in stable patients with CF and PCD (25 subjects per group) on 2 consecutive nights. Results: The median number of coughs/h in the HS, CF, and PCD groups was 0.0, 1.3, and 0.5 on the first night and 0.0, 2.3, and 0.2 on the second night, respectively. Patients with CF and PCD coughed more than HS (p < 0.001 and p = 0.009, respectively) and CF patients coughed more than PCD patients (p = 0.023). A multivariable mixed model analysis revealed forced expiratory volume in 1 s as an independent risk factor for increased cough frequency in patients. The reliability for repeated measurements was higher for cough epochs/h than for coughs/h (intraclass correlation coefficient: 0.75 and 0.49, respectively). Conclusions: Patients with CF cough more than patients with PCD. The cough frequency in CF and PCD is associated with parameters reflecting disease severity. Cough frequency is a possible endpoint in clinical trials and cough epochs/h may be more useful than coughs/h. Cough is a key symptom in patients with cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). The study objectives were to test whether cough is related to parameters reflecting their disease severity and whether CF and PCD differ in cough frequency. In this prospective observational study, we used a microphone-based monitoring system (LEOSound® Monitor) to count the coughs in healthy subjects (HS) and in stable patients with CF and PCD (25 subjects per group) on 2 consecutive nights. The median number of coughs/h in the HS, CF, and PCD groups was 0.0, 1.3, and 0.5 on the first night and 0.0, 2.3, and 0.2 on the second night, respectively. Patients with CF and PCD coughed more than HS (p < 0.001 and p = 0.009, respectively) and CF patients coughed more than PCD patients (p = 0.023). A multivariable mixed model analysis revealed forced expiratory volume in 1 s as an independent risk factor for increased cough frequency in patients. The reliability for repeated measurements was higher for cough epochs/h than for coughs/h (intraclass correlation coefficient: 0.75 and 0.49, respectively). Patients with CF cough more than patients with PCD. The cough frequency in CF and PCD is associated with parameters reflecting disease severity. Cough frequency is a possible endpoint in clinical trials and cough epochs/h may be more useful than coughs/h. BACKGROUNDCough is a key symptom in patients with cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). OBJECTIVEThe study objectives were to test whether cough is related to parameters reflecting their disease severity and whether CF and PCD differ in cough frequency. METHODSIn this prospective observational study, we used a microphone-based monitoring system (LEOSound® Monitor) to count the coughs in healthy subjects (HS) and in stable patients with CF and PCD (25 subjects per group) on 2 consecutive nights. RESULTSThe median number of coughs/h in the HS, CF, and PCD groups was 0.0, 1.3, and 0.5 on the first night and 0.0, 2.3, and 0.2 on the second night, respectively. Patients with CF and PCD coughed more than HS (p < 0.001 and p = 0.009, respectively) and CF patients coughed more than PCD patients (p = 0.023). A multivariable mixed model analysis revealed forced expiratory volume in 1 s as an independent risk factor for increased cough frequency in patients. The reliability for repeated measurements was higher for cough epochs/h than for coughs/h (intraclass correlation coefficient: 0.75 and 0.49, respectively). CONCLUSIONSPatients with CF cough more than patients with PCD. The cough frequency in CF and PCD is associated with parameters reflecting disease severity. Cough frequency is a possible endpoint in clinical trials and cough epochs/h may be more useful than coughs/h. |
Author | Kerschke, Laura Omran, Heymut Raidt, Johanna Radine, Andrea Dougherty, Gerard W. Grosse-Onnebrink, Joerg Werner, Claudius |
Author_xml | – sequence: 1 givenname: Andrea surname: Radine fullname: Radine, Andrea – sequence: 2 givenname: Claudius surname: Werner fullname: Werner, Claudius – sequence: 3 givenname: Johanna surname: Raidt fullname: Raidt, Johanna – sequence: 4 givenname: Gerard W. surname: Dougherty fullname: Dougherty, Gerard W. – sequence: 5 givenname: Laura surname: Kerschke fullname: Kerschke, Laura – sequence: 6 givenname: Heymut surname: Omran fullname: Omran, Heymut – sequence: 7 givenname: Joerg orcidid: 0000-0003-2053-4379 surname: Grosse-Onnebrink fullname: Grosse-Onnebrink, Joerg email: joerg.grosse-onnebrink@ukmuenster.de |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30408808$$D View this record in MEDLINE/PubMed |
BookMark | eNptkctO3DAUhq2KqgzQRfcIWWJTFim-xLmwG6VQkFBBDF1HjnPCGDJ2sB1QHoc3JVHorFid23d-naN_D-0YawChH5T8olTkp4SQOOec8S9oQWPGI8JFsoMWhDARpTmnu2jP-0dCqMgy9g3tchKTLCPZAr0VdtNJp7012Db4r1Whd0a2uLD9wxovx3Tw2mNt8CXINqwHvOqrR1DBY2nqqX8rgwYz1q86rHEx-KAVvtCVs9PiBN06vZFuwIVu9RR_D_5JG_BanuHlOLW-GwX1C-CbyoN7GQXtdMMq9PVwgL42svXw_SPuo38X5_fFZXR98-eqWF5HivM4RKCSSjKeSgU1ECGSJm-kVISnIlc0ZbVKqEiTjEme17SOOVe5UtBQ0WQipxnfRz9n3c7Z5x58KDfaK2hbacD2vmSUM8YESyf0ZEbVeLp30JTd_GFJSTk5Um4dGdmjD9m-2kC9Jf9bMAKHM_Ak3QO4LbDdP_50fHe-momyqxv-Dr74n2E |
CitedBy_id | crossref_primary_10_1183_16000617_0354_2020 crossref_primary_10_1371_journal_pone_0262240 crossref_primary_10_1007_s00431_019_03426_4 crossref_primary_10_1002_ppul_25768 crossref_primary_10_1016_j_rmed_2023_107169 crossref_primary_10_1097_MCP_0000000000000968 crossref_primary_10_1002_ppul_25052 crossref_primary_10_1016_j_jcf_2024_02_011 crossref_primary_10_2147_JAA_S278119 crossref_primary_10_1007_s00431_022_04509_5 |
Cites_doi | 10.1016/S0140-6736(16)00576-6 10.1136/adc.60.5.473 10.1002/ppul.10127 10.1002/ppul.20563 10.1378/chest.14-1481 10.1016/j.jcf.2011.02.003 10.1080/15412555.2017.1338681 10.1165/rcmb.2014-0250OC 10.1002/ppul.20202 10.1016/j.jcf.2010.12.004 10.1002/sim.4780090402 10.1016/j.rmed.2017.08.028 10.1016/j.jcf.2014.03.010 10.1016/j.jcf.2016.07.012 10.1002/ppul.10174 10.3389/fped.2017.00030 10.1002/ppul.22934 10.1159/000321231 10.1183/13993003.00776-2015 10.1016/j.ultramic.2005.04.007 10.1164/rccm.200811-1731OC 10.1378/chest.13-1162 10.2147/COPD.S154539 10.1038/nm.2715 10.1111/j.1469-8986.1966.tb02650.x 10.1183/09031936.00080312 10.1183/09031936.00176608 10.1186/2193-1801-3-40 10.1152/ajplung.00326.2014 10.1172/JCI73469 10.1136/thoraxjnl-2013-203204 10.1002/ppul.23217 10.1183/09031936.00101006 10.1136/thx.2005.050963 10.1002/ppul.21374 10.1016/j.jcf.2011.12.003 10.1016/j.prrv.2007.02.004 10.1378/chest.07-2812 10.1002/ppul.21004 10.1183/09031936.05.00034805 10.1186/1745-9974-1-3 10.1164/rccm.201301-0059CI 10.1002/ppul.22577 |
ContentType | Journal Article |
Copyright | 2018 S. Karger AG, Basel 2018 S. Karger AG, Basel. |
Copyright_xml | – notice: 2018 S. Karger AG, Basel – notice: 2018 S. Karger AG, Basel. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1159/000493323 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1423-0356 |
EndPage | 69 |
ExternalDocumentID | 10_1159_000493323 30408808 493323 |
Genre | Journal Article Comparative Study Observational Study |
GroupedDBID | --- .GJ .XZ 0R~ 0~5 0~B 123 29P 30W 327 34G 36B 39C 3O. 3V. 4.4 53G 5RE 7RQ 7RV 7X7 88E 8AO 8FI 8FJ 8G5 8UI AAWTL AAYIC ABJNI ABPAZ ABUWG ACGFS ACPSR ADAGL ADBBV AENEX AEYAO AFJJK AFKRA AHMBA ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS APPQY AZPMC AZQEC BENPR BKEYQ BPHCQ BVXVI C45 CAG CCPQU COF CS3 CYUIP DU5 DWQXO E0A EBS EJD EMB EMOBN EX3 F5P FB. FYUFA GNUQQ GUQSH HMCUK HZ~ IAO IHR IHW IY7 KUZGX L7B M1P M2O N9A NAPCQ O1H O9- OVD PQQKQ PROAC PSQYO RIG RKO RXVBD SV3 TEORI UJ6 UKHRP WOW ZGI ZXP CGR CUY CVF ECM EIF ITC NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c334t-ec6ba237acede0556f9faac03759c172dc6157682a39d1d433c9ccef15f859183 |
ISSN | 0025-7931 |
IngestDate | Fri Oct 25 22:41:52 EDT 2024 Fri Dec 06 08:13:58 EST 2024 Sat Sep 28 08:27:38 EDT 2024 Thu Sep 05 17:57:50 EDT 2024 Thu Aug 29 12:04:38 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Cystic fibrosis Cough frequency Primary ciliary dyskinesia Objective cough count |
Language | English |
License | Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. 2018 S. Karger AG, Basel. https://www.karger.com/Services/SiteLicenses |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c334t-ec6ba237acede0556f9faac03759c172dc6157682a39d1d433c9ccef15f859183 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
ORCID | 0000-0003-2053-4379 |
PMID | 30408808 |
PQID | 2132225278 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2132225278 karger_primary_493323 crossref_primary_10_1159_000493323 pubmed_primary_30408808 |
PublicationCentury | 2000 |
PublicationDate | 2019-01-01 |
PublicationDateYYYYMMDD | 2019-01-01 |
PublicationDate_xml | – month: 01 year: 2019 text: 2019-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Basel, Switzerland |
PublicationPlace_xml | – name: Basel, Switzerland – name: Switzerland |
PublicationTitle | Respiration |
PublicationTitleAlternate | Respiration |
PublicationYear | 2019 |
References | Levy H, Kalish LA, Huntington I, Weller N, Gerard C, Silverman EK, et al.. Inflammatory markers of lung disease in adult patients with cystic fibrosis. Pediatr Pulmonol. 2007Mar;42(3):256–62. 10.1002/ppul.20563172457358755-6863 Barbato A, Frischer T, Kuehni CE, Snijders D, Azevedo I, Baktai G, et al.. Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Respir J. 2009Dec;34(6):1264–76. 10.1183/09031936.00176608199489090903-1936 Kerem E, Wilschanski M, Miller NL, Pugatsch T, Cohen T, Blau H, et al.. Ambulatory quantitative waking and sleeping cough assessment in patients with cystic fibrosis. J Cyst Fibros. 2011May;10(3):193–200. 10.1016/j.jcf.2011.02.003214590511569-1993 Leconte S, Ferrant D, Dory V, Degryse J. Validated methods of cough assessment: a systematic review of the literature. Respiration. 2011;81(2):161–74. 10.1159/000321231210793811423-0356 Smyth AR, Bell SC, Bojcin S, Bryon M, Duff A, Flume P, et al.; European Cystic Fibrosis Society. European Cystic Fibrosis S: European cystic fibrosis society standards of care: Best practice guidelines. J Cyst Fibros. 2014May;13Suppl 1:S23–42. 10.1016/j.jcf.2014.03.010248567751569-1993 Chinn S. The assessment of methods of measurement. Stat Med. 1990Apr;9(4):351–62. 10.1002/sim.478009040223629750277-6715 Cohen-Cymberknoh M, Weigert N, Gileles-Hillel A, Breuer O, Simanovsky N, Boon M, et al.. Clinical impact of Pseudomonas aeruginosa colonization in patients with Primary Ciliary Dyskinesia. Respir Med. 2017Oct;131:241–6. 10.1016/j.rmed.2017.08.028289470380954-6111 Archer LN, Simpson H. Night cough counts and diary card scores in asthma. Arch Dis Child. 1985May;60(5):473–4. 10.1136/adc.60.5.47340151540003-9888 Knowles MR, Daniels LA, Davis SD, Zariwala MA, Leigh MW. Primary ciliary dyskinesia. Recent advances in diagnostics, genetics, and characterization of clinical disease. Am J Respir Crit Care Med. 2013Oct;188(8):913–22. 10.1164/rccm.201301-0059CI237961961073-449X Kent BD, Lane SJ, van Beek EJ, Dodd JD, Costello RW, Tiddens HA. Asthma and cystic fibrosis: a tangled web. Pediatr Pulmonol. 2014Mar;49(3):205–13. 10.1002/ppul.22934244208178755-6863 Cameron AT. Essentials of count data regression. In: Baltagi B, editor. A companion to theoretical econometrics. 2001. pp. 331–48. Collawn JF, Matalon S. CFTR and lung homeostasis. Am J Physiol Lung Cell Mol Physiol. 2014Dec;307(12):L917–23. 10.1152/ajplung.00326.2014253810271040-0605 Coyle MA, Keenan DB, Henderson LS, Watkins ML, Haumann BK, Mayleben DW, et al.. Evaluation of an ambulatory system for the quantification of cough frequency in patients with chronic obstructive pulmonary disease. Cough. 2005Aug;1(1):3. 10.1186/1745-9974-1-3162709231745-9974 Keiser NW, Birket SE, Evans IA, Tyler SR, Crooke AK, Sun X, et al.. Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungs. Am J Respir Cell Mol Biol. 2015Jun;52(6):683–94. 10.1165/rcmb.2014-0250OC253176691044-1549 Smith JA, Owen EC, Jones AM, Dodd ME, Webb AK, Woodcock A. Objective measurement of cough during pulmonary exacerbations in adults with cystic fibrosis. Thorax. 2006May;61(5):425–9. 10.1136/thx.2005.050963164492660040-6376 Elborn JS. Cystic fibrosis. Lancet. 2016Nov;388(10059):2519–31. 10.1016/S0140-6736(16)00576-6271406700140-6736 Santamaria F, Montella S, Tiddens HA, Guidi G, Casotti V, Maglione M, et al.. Structural and functional lung disease in primary ciliary dyskinesia. Chest. 2008Aug;134(2):351–7. 10.1378/chest.07-2812184036630012-3692 Koehler U, Brandenburg U, Weissflog A, Sohrabi K, Groß V. [LEOSound, an innovative procedure for acoustic long-term monitoring of asthma symptoms (wheezing and coughing) in children and adults]. Pneumologie. 2014Apr;68(4):277–81.246156661438-8790 Bakker EM, van der Meijden JC, Nieuwhof EM, Hop WC, Tiddens HA. Determining presence of lung disease in young children with cystic fibrosis: lung clearance index, oxygen saturation and cough frequency. J Cyst Fibros. 2012May;11(3):223–30. 10.1016/j.jcf.2011.12.003222656031569-1993 Cohen-Cymberknoh M, Kerem E, Ferkol T, Elizur A. Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications. Thorax. 2013Dec;68(12):1157–62. 10.1136/thoraxjnl-2013-203204237042280040-6376 Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al.; ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012Dec;40(6):1324–43. 10.1183/09031936.00080312227436750903-1936 Cohen TS, Prince A. Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med. 2012Apr;18(4):509–19. 10.1038/nm.2715224814181078-8956 Hamutcu R, Francis J, Karakoc F, Bush A. Objective monitoring of cough in children with cystic fibrosis. Pediatr Pulmonol. 2002Nov;34(5):331–5. 10.1002/ppul.10174123574768755-6863 Cohen-Cymberknoh M, Simanovsky N, Hiller N, Hillel AG, Shoseyov D, Kerem E. Differences in disease expression between primary ciliary dyskinesia and cystic fibrosis with and without pancreatic insufficiency. Chest. 2014Apr;145(4):738–44. 10.1378/chest.13-1162240916060012-3692 Shah SA, Santago P, Rubin BK. Quantification of biopolymer filament structure. Ultramicroscopy. 2005Oct;104(3-4):244–54. 10.1016/j.ultramic.2005.04.007159612310304-3991 Fischer P, Gross V, Kroenig J, Weissflog A, Hildebrandt O, Sohrabi K, et al.. Description of nighttime cough epochs in patients with stable COPD GOLD II-IV. Int J Chron Obstruct Pulmon Dis. 2018Apr;13:1071–8. 10.2147/COPD.S154539296623091176-9106 Goutaki M, Halbeisen FS, Spycher BD, Maurer E, Belle F, Amirav I, et al.. Swiss PCDG, French Reference Centre for Rare Lung D: Growth and nutritional status, and their association with lung function: A study from the international primary ciliary dyskinesia cohort. Eur Respir J. 2017;•••:50.0903-1936 Krönig J, Hildebrandt O, Weissflog A, Cassel W, Gross V, Sohrabi K, et al.. Long-term recording of night-time respiratory symptoms in patients with stable copd ii-iv. COPD. 2017Oct;14(5):498–503. 10.1080/15412555.2017.1338681287152321541-2555 Cogen J, Emerson J, Sanders DB, Ren C, Schechter MS, Gibson RL, et al.; EPIC Study Group. Risk factors for lung function decline in a large cohort of young cystic fibrosis patients. Pediatr Pulmonol. 2015Aug;50(8):763–70. 10.1002/ppul.23217260619148755-6863 Aly SS, Zhao J, Li B, Jiang J. Reliability of environmental sampling culture results using the negative binomial intraclass correlation coefficient. Springerplus. 2014Jan;3(1):40. 10.1186/2193-1801-3-40245167832193-1801 von Heydebrand M, Hildebrandt O, Cassel W, Schäfer A, Kesper K, Weissflog A, et al.. [Apnea Detection by Means of Respiratory Sound Recordings and Polysomnography - A Comparative Study]. Pneumologie. 2017Sep;71(9):594–9.287599341438-8790 Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002Aug;34(2):91–100. 10.1002/ppul.10127121127748755-6863 Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al.; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005Aug;26(2):319–38. 10.1183/09031936.05.00034805160558820903-1936 Proesmans M, Els C, Vermeulen F, De Boeck K. Change in IgG and evolution of lung function in children with cystic fibrosis. J Cyst Fibros. 2011Mar;10(2):128–31. 10.1016/j.jcf.2010.12.004212202151569-1993 Canning BJ, Chang AB, Bolser DC, Smith JA, Mazzone SB, McGarvey L, et al.; CHEST Expert Cough Panel. Anatomy and neurophysiology of cough: CHEST Guideline and Expert Panel report. Chest. 2014Dec;146(6):1633–48. 10.1378/chest.14-1481251885300012-3692 Agnew HWJr, WebbWB, Williams RL. The first night effect: an EEG study of sleep. Psychophysiology. 1966Jan;2(3):263–6. 10.1111/j.1469-8986.1966.tb02650.x59035790048-5772 Werner C, Lablans M, Ataian M, Raidt J, Wallmeier J, Große-Onnebrink J, et al.. An international registry for primary ciliary dyskinesia. Eur Respir J. 2016Mar;47(3):849–59. 10.1183/13993003.00776-2015266591070903-1936 Henderson AG, Ehre C, Button B, Abdullah LH, Cai LH, Leigh MW, et al.. Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure. J Clin Invest. 2014Jul;124(7):3047–60. 10.1172/JCI73469248928080021-9738 Gillissen A, Richter A, Oster H: Clinical efficacy of short-term treatment with extra-fine hfa beclomethasone dipropionate in patients with post-infectious persistent cough. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2007;58 Suppl 5:223-232. Redding GJ, Carter ER. Chronic suppurative lung disease in children: definition and spectrum of disease. Front Pediatr. 2017Feb;5:30. 10.3389/fped.2017.00030282896732296-2360 Keating C, Poor AD, Liu X, Chiuzan C, Backenroth D, Zhang Y, et al.. Reduced survival in adult cystic fibrosis despite attenuated lung function decline. J Cyst Fibros. 2017Jan;16(1):78–84. 10.1016/j.jcf.2016.07.012275223111569-1993 Morice AH, Fontana GA, Belvisi MG, Birring SS, Chung KF, Dicpinigaitis PV, et al.; European Respiratory Society (ERS). ERS guidelines on the assessment of cough. Eur Respir J. 2007Jun;29(6):1256–76. 10.1183/09031936.00101006175407880903-1936 Sanders DB, Bittner RC, Rosenfeld M, Redding GJ, Goss CH. Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis. Pediatr Pulmonol. 2011Apr;46(4):393–400. 10.1002/ppul.21374209678458755-6863 van der Giessen L, Loeve M, de Jongste J, Hop W, Tiddens H. Nocturnal cough in children with stable cystic fibrosis. Pediatr Pulmonol. 2009Sep;44(9):859–65. 10.1002/ppul.21004196704028755-6863 Rubin BK. Mucus structure and properties in cystic fibrosis. Paediatr Respir Rev. 2007Mar;8(1):4–7. 10.1016/j.prrv.2007.02.004174199721526-0542 Marthin JK, Petersen N, Skovgaard LT, Nielsen KG. Lung function ref13 ref35 ref12 ref34 ref15 ref37 ref14 ref36 ref31 ref30 ref11 ref33 ref10 ref32 ref2 ref1 ref17 ref39 ref16 ref38 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref42 ref41 ref22 ref21 ref43 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref40 |
References_xml | – ident: ref33 doi: 10.1016/S0140-6736(16)00576-6 – ident: ref3 doi: 10.1136/adc.60.5.473 – ident: ref19 doi: 10.1002/ppul.10127 – ident: ref18 doi: 10.1002/ppul.20563 – ident: ref27 doi: 10.1378/chest.14-1481 – ident: ref25 doi: 10.1016/j.jcf.2011.02.003 – ident: ref9 doi: 10.1080/15412555.2017.1338681 – ident: ref30 doi: 10.1165/rcmb.2014-0250OC – ident: ref12 doi: 10.1002/ppul.20202 – ident: ref17 doi: 10.1016/j.jcf.2010.12.004 – ident: ref22 doi: 10.1002/sim.4780090402 – ident: ref16 doi: 10.1016/j.rmed.2017.08.028 – ident: ref5 doi: 10.1016/j.jcf.2014.03.010 – ident: ref41 doi: 10.1016/j.jcf.2016.07.012 – ident: ref2 doi: 10.1002/ppul.10174 – ident: ref28 doi: 10.3389/fped.2017.00030 – ident: ref43 doi: 10.1002/ppul.22934 – ident: ref4 doi: 10.1159/000321231 – ident: ref7 doi: 10.1183/13993003.00776-2015 – ident: ref35 doi: 10.1016/j.ultramic.2005.04.007 – ident: ref39 doi: 10.1164/rccm.200811-1731OC – ident: ref29 doi: 10.1378/chest.13-1162 – ident: ref8 doi: 10.2147/COPD.S154539 – ident: ref37 doi: 10.1038/nm.2715 – ident: ref13 doi: 10.1111/j.1469-8986.1966.tb02650.x – ident: ref15 doi: 10.1183/09031936.00080312 – ident: ref6 doi: 10.1183/09031936.00176608 – ident: ref23 doi: 10.1186/2193-1801-3-40 – ident: ref31 doi: 10.1152/ajplung.00326.2014 – ident: ref32 doi: 10.1172/JCI73469 – ident: ref36 doi: 10.1136/thoraxjnl-2013-203204 – ident: ref21 doi: 10.1002/ppul.23217 – ident: ref10 doi: 10.1183/09031936.00101006 – ident: ref11 doi: 10.1136/thx.2005.050963 – ident: ref20 doi: 10.1002/ppul.21374 – ident: ref24 doi: 10.1016/j.jcf.2011.12.003 – ident: ref34 doi: 10.1016/j.prrv.2007.02.004 – ident: ref42 doi: 10.1378/chest.07-2812 – ident: ref1 doi: 10.1002/ppul.21004 – ident: ref14 doi: 10.1183/09031936.05.00034805 – ident: ref26 doi: 10.1186/1745-9974-1-3 – ident: ref38 doi: 10.1164/rccm.201301-0059CI – ident: ref40 doi: 10.1002/ppul.22577 |
SSID | ssj0015882 |
Score | 2.3190305 |
Snippet | Background: Cough is a key symptom in patients with cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). Objective: The study objectives were to test... Cough is a key symptom in patients with cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). The study objectives were to test whether cough is related... BACKGROUNDCough is a key symptom in patients with cystic fibrosis (CF) and primary ciliary dyskinesia (PCD). OBJECTIVEThe study objectives were to test whether... |
SourceID | proquest crossref pubmed karger |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 60 |
SubjectTerms | Adolescent Adult Child Ciliary Motility Disorders - complications Ciliary Motility Disorders - diagnosis Circadian Rhythm - physiology Clinical Investigations Cough - diagnosis Cough - etiology Cystic Fibrosis - complications Cystic Fibrosis - diagnosis Female Follow-Up Studies Forced Expiratory Volume - physiology Healthy Volunteers Humans Male Middle Aged Monitoring, Physiologic - methods Prospective Studies Respiratory Function Tests Severity of Illness Index Young Adult |
Title | Comparison of Nocturnal Cough Analysis in Healthy Subjects and in Patients with Cystic Fibrosis and Primary Ciliary Dyskinesia: A Prospective Observational Study |
URI | https://karger.com/doi/10.1159/000493323 https://www.ncbi.nlm.nih.gov/pubmed/30408808 https://search.proquest.com/docview/2132225278 |
Volume | 97 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELe6Dk17QfwZUBiTQfBUZWtju0l4K2HThESZpk3sLXIcR4SNpOrah_Ft-CZ8NHz-lxSYBLyklZvESu7Xu7Pv7ncIvSpDGoMlD8Y0jwPKJVDeslFQyIhPch5PIsP2OZscn9P3F-yi1_vRyVpaLfN98e2PdSX_I1U1puQKVbL_IFl_UzWgviv5qqOSsDr-lYzTbhPB4ayBcECtdwOg9Y7nG9F0VpDmpfXEF52_YUiXgKG_amvc0htgbR4eqSV0AxeaSgJDR5FWVxV8vru5voRU-YqbovaTReOqNYcfc7_HCyQjnrnWEYDbsH4n9H8KKfzSZ1a2NkIubCVOesVXRbVqU_J5VSxtEjGva38FrAQ-A1Gw2elfAItkGr6ejj7td3c2oJjK72y4SgOg07RWQhoFrdy_YEQMGbnT4CbDdw2pRh2bVgXWsJuWML-bDJaYHEuaEGJqnzvQmX_V2CFK1ylNF7dW0-cymss20CZQMdI-2nx7ODs59ZEsFsehbxusnsWyW6lZD_yc22jLTbDmHt25hGqAxe2LH-0End1Dd-3qBU8NFO-jnqwfoK0PNj_jIfreIhI3JfaIxBqR2CESVzW2iMQOkViBDcYdIjEgEhtEYodIfZJFJLaIxC0i3-Ap7uARr-ERazzuoPOjw7P0OLBNQAJBCF0GUiiVEZKIC1lIYH4qk5JzAa2bE6G870Ion1ytmUNOkmJcUEJEIoQsx6wEasaYPEL9uqnlE4RZmEeTSU4oK8Y0ZlGeiILSmMcsh1fPB-ile_fZ3DxKptfILMm8rAZox0jFn-LGd38ZVxrU_JTNi3KAXjgZZkqBQ1SO17JZXWehDnayMIoH6LERrr-FQ8XTWyZ9hrbbP84u6i8XK_lcOcnLfA9tRBfRnkXjT6XTv1w |
link.rule.ids | 314,780,784,27924,27925,31720,33745 |
linkProvider | ProQuest |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+Nocturnal+Cough+Analysis+in+Healthy+Subjects+and+in+Patients+with+Cystic+Fibrosis+and+Primary+Ciliary+Dyskinesia%3A+A+Prospective+Observational+Study&rft.jtitle=Respiration&rft.au=Radine%2C+Andrea&rft.au=Werner%2C+Claudius&rft.au=Raidt%2C+Johanna&rft.au=Dougherty%2C+Gerard%C2%A0W.&rft.date=2019-01-01&rft.issn=0025-7931&rft.eissn=1423-0356&rft.volume=97&rft.issue=1&rft.spage=60&rft.epage=69&rft_id=info:doi/10.1159%2F000493323&rft_id=info%3Apmid%2F30408808&rft.externalDocID=493323 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0025-7931&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0025-7931&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0025-7931&client=summon |